Primary Site >> Biliary tract Cancer
Gene >> FLT1
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: [Effects of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotide on mRNA and expression of VEGF, flt-1, and kinase insert domain containing receptor and VEGF excretion in human gallbladder carcinoma cells]. PMID: 18478945 |
Ref: Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. PMID: 18395502 |
Ref: Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. PMID: 20565817 |
Ref: EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. PMID: 23704979 |
Ref: Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma. PMID: 24755544 |
Ref: Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. PMID: 26967384 |
Ref: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers. PMID: 29416916 Ref: Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. PMID: 29925934 Ref: Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. PMID: 29935812 |